TY - JOUR AU - Arber, D. A. AU - Orazi, A. AU - Hasserjian, R. AU - Borowitz, M. J. AU - Beau, M. M. AU - Bloomfield, C. D. PY - 2016 DA - 2016// TI - The 2016 revision to the World Health Organization classi fi cation of myeloid neoplasms and acute leukemia JO - Blood. VL - 127 UR - https://doi.org/10.1182/blood-2016-03-643544 DO - 10.1182/blood-2016-03-643544 ID - Arber2016 ER - TY - STD TI - Rumi E, Cazzola M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood. 2016; blood-2016-10-695957. Available from: http://www.bloodjournal.org/lookup/doi/10.1182/blood-2016-10-695957. Accessed June 2018. UR - http://www.bloodjournal.org/lookup/doi/10.1182/blood-2016-10-695957 ID - ref2 ER - TY - JOUR AU - Titmarsh, G. J. AU - Duncombe, A. S. AU - Mcmullin, M. F. AU - O’Rorke, M. AU - Mesa, R. AU - Vocht, F. PY - 2014 DA - 2014// TI - How common are myeloproliferative neoplasms? A systematic review and meta-analysis JO - Am J Hematol VL - 89 UR - https://doi.org/10.1002/ajh.23690 DO - 10.1002/ajh.23690 ID - Titmarsh2014 ER - TY - JOUR AU - Ferlay, J. a. c. q. u. e. s. AU - Soerjomataram, I. s. a. b. e. l. l. e. AU - Dikshit, R. a. j. e. s. h. AU - Eser, S. u. l. t. a. n. AU - Mathers, C. o. l. i. n. AU - Rebelo, M. a. r. i. s. e. AU - Parkin, D. o. n. a. l. d. M. a. x. w. e. l. l. AU - Forman, D. a. v. i. d. AU - Bray, F. r. e. d. d. i. e. PY - 2014 DA - 2014// TI - Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 JO - International Journal of Cancer VL - 136 UR - https://doi.org/10.1002/ijc.29210 DO - 10.1002/ijc.29210 ID - Ferlay2014 ER - TY - STD TI - S MH, C CP, C BD, S D, Q M, L JF, et al. Descripción de las características clínicas de las neoplasias mieloproliferativas crónicas ( NMPC ) Description of the clinical characteristics of chronic myeloproliferative neoplasms ( MPNs ) First report of the colombian registry of MPNs. 2017;35–41. ID - ref5 ER - TY - JOUR AU - Dameshek, W. PY - 1951 DA - 1951// TI - Some speculations on the myeloproliferative syndromes JO - Blood VL - 6 ID - Dameshek1951 ER - TY - JOUR AU - James, C. AU - Ugo, V. AU - Couédic, J. -. P. AU - Staerk, J. AU - Delhommeau, F. AU - Lacout, C. PY - 2005 DA - 2005// TI - A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera JO - Nature VL - 434 UR - https://doi.org/10.1038/nature03546 DO - 10.1038/nature03546 ID - James2005 ER - TY - JOUR AU - Pikman, Y. AU - Lee, B. H. AU - Mercher, T. AU - McDowell, E. AU - Ebert, B. L. AU - Gozo, M. PY - 2006 DA - 2006// TI - MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia JO - PLoS Med VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030270 DO - 10.1371/journal.pmed.0030270 ID - Pikman2006 ER - TY - STD TI - Nangalia J, Massie CEE, Baxter EJJ, Nice FLL, Gundem G, Wedge DCC, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med. 2013;369(25):2391–405. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966280/. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3966280. UR - http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3966280 ID - ref9 ER - TY - JOUR AU - Klampfl, T. AU - Gisslinger, H. AU - Harutyunyan, A. S. AU - Nivarthi, H. AU - Rumi, E. AU - Milosevic, J. D. PY - 2013 DA - 2013// TI - Somatic mutations of calreticulin in myeloproliferative neoplasms JO - N Engl J med VL - 369 UR - https://doi.org/10.1056/NEJMoa1311347 DO - 10.1056/NEJMoa1311347 ID - Klampfl2013 ER - TY - JOUR AU - Vainchenker, W. AU - Kralovics, R. PY - 2017 DA - 2017// TI - Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms JO - Blood. VL - 129 UR - https://doi.org/10.1182/blood-2016-10-695940 DO - 10.1182/blood-2016-10-695940 ID - Vainchenker2017 ER - TY - JOUR AU - Rumi, E. AU - Pietra, D. AU - Ferretti, V. AU - Klampfl, T. AU - Harutyunyan, A. S. AU - Milosevic, J. D. PY - 2014 DA - 2014// TI - JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes JO - Blood United States VL - 123 ID - Rumi2014 ER - TY - JOUR AU - Rumi, E. AU - Pietra, D. AU - Pascutto, C. AU - Guglielmelli, P. AU - Martínez-Trillos, A. AU - Casetti, I. PY - 2014 DA - 2014// TI - Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis JO - Blood. VL - 124 UR - https://doi.org/10.1182/blood-2014-05-578435 DO - 10.1182/blood-2014-05-578435 ID - Rumi2014 ER - TY - JOUR AU - Aranaz, P. AU - Ormazabal, C. AU - Hurtado, C. AU - Erquiaga, I. AU - Calasanz, M. J. AU - Garcia-Delgado, M. PY - 2010 DA - 2010// TI - A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes JO - Cancer Genet Cytogenet United States VL - 199 UR - https://doi.org/10.1016/j.cancergencyto.2010.01.002 DO - 10.1016/j.cancergencyto.2010.01.002 ID - Aranaz2010 ER - TY - JOUR AU - Trifa, A. P. AU - Banescu, C. AU - Dima, D. AU - Bojan, A. S. AU - Tevet, M. AU - Moldovan, V. G. PY - 2016 DA - 2016// TI - Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C>T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms JO - Hematology England VL - 21 UR - https://doi.org/10.1080/10245332.2016.1163889 DO - 10.1080/10245332.2016.1163889 ID - Trifa2016 ER - TY - JOUR AU - Neri, A. AU - Fracchiolla, N. S. AU - Radaelli, F. AU - Boletini, A. AU - Ribera, S. AU - Migliorini, C. PY - 1996 DA - 1996// TI - p53 tumour suppressor gene and RAS oncogenes: molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia JO - Br J Haematol England VL - 93 UR - https://doi.org/10.1046/j.1365-2141.1996.d01-1690.x DO - 10.1046/j.1365-2141.1996.d01-1690.x ID - Neri1996 ER - TY - JOUR AU - Aviram, A. AU - Witenberg, B. AU - Shaklai, M. AU - Blickstein, D. PY - 2003 DA - 2003// TI - Detection of methylated ABL1 promoter in Philadelphia-negative myeloproliferative disorders JO - Blood Cells Mol Dis United States VL - 30 UR - https://doi.org/10.1016/S1079-9796(03)00015-9 DO - 10.1016/S1079-9796(03)00015-9 ID - Aviram2003 ER - TY - JOUR AU - Kissova, J. AU - Bulikova, A. AU - Ovesna, P. AU - Bourkova, L. AU - Penka, M. PY - 2014 DA - 2014// TI - Increased mean platelet volume and immature platelet fraction as potential predictors of thrombotic complications in BCR/ABL-negative myeloproliferative neoplasms JO - Int J Hematol. Japan VL - 100 UR - https://doi.org/10.1007/s12185-014-1673-0 DO - 10.1007/s12185-014-1673-0 ID - Kissova2014 ER - TY - JOUR AU - Kander, E. M. AU - Raza, S. AU - Zhou, Z. AU - Gao, J. AU - Zakarija, A. AU - McMahon, B. J. PY - 2015 DA - 2015// TI - Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort JO - Int J Hematol. Japan VL - 102 UR - https://doi.org/10.1007/s12185-015-1871-4 DO - 10.1007/s12185-015-1871-4 ID - Kander2015 ER - TY - JOUR AU - Qin, Y. AU - Wang, X. AU - Zhao, C. AU - Wang, C. AU - Yang, Y. PY - 2015 DA - 2015// TI - The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis JO - Int J Hematol Japan VL - 102 UR - https://doi.org/10.1007/s12185-015-1808-y DO - 10.1007/s12185-015-1808-y ID - Qin2015 ER - TY - JOUR AU - Kong, H. AU - Liu, Y. AU - Luo, S. AU - Li, Q. AU - Wang, Q. PY - 2016 DA - 2016// TI - Frequency of calreticulin (CALR) mutation and its clinical prognostic significance in essential Thrombocythemia and primary myelofibrosis: a meta-analysis JO - Intern Med Japan VL - 55 UR - https://doi.org/10.2169/internalmedicine.55.6214 DO - 10.2169/internalmedicine.55.6214 ID - Kong2016 ER - TY - JOUR AU - Kourie, H. R. AU - Ameye, L. AU - Paesmans, M. AU - Bron, D. PY - 2016 DA - 2016// TI - Improved survival of calreticulin-mutated patients compared with Janus kinase 2 in primary myelofibrosis: a meta-analysis JO - Clin Lymphoma Myeloma Leuk United States VL - 16 UR - https://doi.org/10.1016/j.clml.2016.01.009 DO - 10.1016/j.clml.2016.01.009 ID - Kourie2016 ER - TY - JOUR AU - Pei, Y. -. Q. AU - Wu, Y. AU - Wang, F. AU - Cui, W. PY - 2016 DA - 2016// TI - Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis. Ann Hematol JO - Germany VL - 95 ID - Pei2016 ER - TY - JOUR AU - Lengfelder, E. PY - 2013 DA - 2013// TI - Diagnosis and therapy of polycythemia vera in the era of JAK2 JO - Dtsch med Wochenschr. Germany VL - 138 UR - https://doi.org/10.1055/s-0032-1332856 DO - 10.1055/s-0032-1332856 ID - Lengfelder2013 ER - TY - JOUR AU - Anderson, L. A. AU - Duncombe, A. S. AU - Hughes, M. AU - Mills, M. E. AU - Wilson, J. C. AU - McMullin, M. F. PY - 2012 DA - 2012// TI - Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms JO - Am J Hematol United States VL - 87 UR - https://doi.org/10.1002/ajh.22212 DO - 10.1002/ajh.22212 ID - Anderson2012 ER - TY - JOUR AU - Moher, D. a. v. i. d. AU - Liberati, A. l. e. s. s. a. n. d. r. o. AU - Tetzlaff, J. e. n. n. i. f. e. r. AU - Altman, D. o. u. g. l. a. s. G. PY - 2009 DA - 2009// TI - Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement JO - PLoS Medicine VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000097 DO - 10.1371/journal.pmed.1000097 ID - Moher2009 ER - TY - STD TI - Schlosser RW, Wendt O, Bhavnani S, Nail-chiwetalu B. Review use of information-seeking strategies for developing systematic reviews and engaging in evidence-based practice : the application of traditional and comprehensive pearl growing. A review. 2006. ID - ref27 ER - TY - JOUR AU - Elm, E. AU - Altman, D. G. AU - Egger, M. AU - Pocock, S. J. AU - Gotzsche, P. C. AU - Vandenbroucke, J. P. PY - 2008 DA - 2008// TI - The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies JO - J Clin Epidemiol United States VL - 61 UR - https://doi.org/10.1016/j.jclinepi.2007.11.008 DO - 10.1016/j.jclinepi.2007.11.008 ID - Elm2008 ER - TY - JOUR AU - Hsu, H. -. C. AU - Tan, L. -. Y. AU - Au, L. -. C. AU - Lee, Y. -. M. AU - Lieu, C. -. H. AU - Tsai, W. -. H. PY - 2004 DA - 2004// TI - Detection of bcr-abl gene expression at a low level in blood cells of some patients with essential thrombocythemia JO - J Lab Clin Med United States VL - 143 UR - https://doi.org/10.1016/j.lab.2003.10.007 DO - 10.1016/j.lab.2003.10.007 ID - Hsu2004 ER - TY - JOUR AU - Jelinek, J. AU - Oki, Y. AU - Gharibyan, V. AU - Bueso-Ramos, C. AU - Prchal, J. T. AU - Verstovsek, S. PY - 2005 DA - 2005// TI - JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia JO - Blood. United States VL - 106 ID - Jelinek2005 ER - TY - JOUR AU - Jost, E. AU - do Ó, N. AU - Dahl, E. AU - Maintz, C. E. AU - Jousten, P. AU - Habets, L. AU - Wilop, S. AU - Herman, J. G. AU - Osieka, R. AU - Galm, O. PY - 2007 DA - 2007// TI - Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404513 DO - 10.1038/sj.leu.2404513 ID - Jost2007 ER - TY - JOUR AU - Zhang, S. AU - Li, W. AU - Song, J. AU - Xu, W. AU - Qiu, H. AU - Li, J. PY - 2007 DA - 2007// TI - The investigation of JAK2 V617F point mutation in myeloproliferative disorders by allele-specific polymerase chain reaction in combination with sequence analysis JO - Zhonghua Yi Xue Za Zhi. China VL - 87 ID - Zhang2007 ER - TY - JOUR AU - Najfeld, V. AU - Cozza, A. AU - Berkofsy-Fessler, W. AU - Prchal, J. AU - Scalise, A. PY - 2007 DA - 2007// TI - Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms JO - Exp Hematol Netherlands VL - 35 UR - https://doi.org/10.1016/j.exphem.2007.08.025 DO - 10.1016/j.exphem.2007.08.025 ID - Najfeld2007 ER - TY - JOUR AU - Suzuki, R. AU - Onizuka, M. AU - Kojima, M. AU - Shimada, M. AU - Tsuboi, K. AU - Ogawa, Y. PY - 2007 DA - 2007// TI - Infrequent hypermethylation of WIF-1 promoter in BCR/ABL-negative myeloproliferative disorders JO - Tokai J Exp Clin Med Japan VL - 32 ID - Suzuki2007 ER - TY - JOUR AU - Xu, W. AU - Li, J. -. Y. AU - Xia, J. AU - Zhang, S. -. J. AU - Fan, L. AU - Qiao, C. PY - 2008 DA - 2008// TI - MPL W515L mutation in Chinese patients with myeloproliferative diseases JO - Leuk Lymphoma. England VL - 49 UR - https://doi.org/10.1080/10428190802035966 DO - 10.1080/10428190802035966 ID - Xu2008 ER - TY - JOUR AU - Lucia, E. AU - Martino, B. AU - Mammi, C. AU - Vigna, E. AU - Mazzone, C. AU - Gentile, M. PY - 2008 DA - 2008// TI - The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods JO - Leuk Lymphoma England VL - 49 UR - https://doi.org/10.1080/10428190802290652 DO - 10.1080/10428190802290652 ID - Lucia2008 ER - TY - JOUR AU - Tefferi, A. AU - Sirhan, S. AU - Sun, Y. AU - Lasho, T. AU - Finke, C. M. AU - Weisberger, J. PY - 2009 DA - 2009// TI - Oligonucleotide array CGH studies in myeloproliferative neoplasms: comparison with JAK2V617F mutational status and conventional chromosome analysis JO - Leuk Res. England VL - 33 UR - https://doi.org/10.1016/j.leukres.2008.09.009 DO - 10.1016/j.leukres.2008.09.009 ID - Tefferi2009 ER - TY - JOUR AU - Tefferi, A. AU - Pardanani, A. AU - Lim, K. -. H. AU - Abdel-Wahab, O. AU - Lasho, T. L. AU - Patel, J. PY - 2009 DA - 2009// TI - TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis JO - Leukemia England VL - 23 UR - https://doi.org/10.1038/leu.2009.47 DO - 10.1038/leu.2009.47 ID - Tefferi2009 ER - TY - JOUR AU - Tripodi, J. AU - Hoffman, R. AU - Najfeld, V. AU - Weinberg, R. PY - 2010 DA - 2010// TI - Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms JO - Cancer Manag Res New Zealand VL - 2 ID - Tripodi2010 ER - TY - JOUR AU - Chen, X. AU - Qi, X. AU - Tan, Y. AU - Xu, Z. AU - Xu, A. AU - Zhang, L. PY - 2011 DA - 2011// TI - Detection of MPL exon10 mutations in 103 Chinese patients with JAK2V617F-negative myeloproliferative neoplasms JO - Blood Cells Mol Dis. United States VL - 47 UR - https://doi.org/10.1016/j.bcmd.2011.04.004 DO - 10.1016/j.bcmd.2011.04.004 ID - Chen2011 ER - TY - JOUR AU - Toyama, K. AU - Karasawa, M. AU - Yokohama, A. AU - Mitsui, T. AU - Uchiumi, H. AU - Saitoh, T. PY - 2011 DA - 2011// TI - Differences in the JAK2 and MPL mutation status in the cell lineages of the bcr/abl-negative chronic myeloproliferative neoplasm subtypes JO - Intern Med. Japan VL - 50 UR - https://doi.org/10.2169/internalmedicine.50.5429 DO - 10.2169/internalmedicine.50.5429 ID - Toyama2011 ER - TY - JOUR AU - Benmoussa, A. AU - Dehbi, H. AU - Fehri, S. AU - Quessar, A. AU - Nadifi, S. PY - 2011 DA - 2011// TI - JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects JO - Pathol Biol (Paris). France VL - 59 UR - https://doi.org/10.1016/j.patbio.2009.06.005 DO - 10.1016/j.patbio.2009.06.005 ID - Benmoussa2011 ER - TY - JOUR AU - Silva, R. R. AU - Domingues Hatzlhofer, B. L. AU - Machado, C. G. AU - Lima, A. S. AU - Albuquerque, D. M. AU - Santos, M. N. N. PY - 2012 DA - 2012// TI - JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil JO - Genet Test Mol Biomarkers. United States VL - 16 UR - https://doi.org/10.1089/gtmb.2011.0272 DO - 10.1089/gtmb.2011.0272 ID - Silva2012 ER - TY - JOUR AU - Zhang, X. AU - Maimaitili, Y. AU - Li, Y. AU - An, L. AU - Mao, M. AU - Fu, L. PY - 2012 DA - 2012// TI - Detection and clinical significance of JAK2 V617F mutation in Chinese and Uyghur patients with chronic myeloproliferative in Xinjiang JO - Zhonghua Xue ye Xue Za Zhi. China VL - 33 ID - Zhang2012 ER - TY - JOUR AU - Ho, C. -. L. AU - Wu, Y. -. Y. AU - Hung, H. -. M. AU - Chang, P. -. Y. AU - Kao, W. -. Y. AU - Chen, Y. -. C. PY - 2012 DA - 2012// TI - Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis JO - J Formos Med Assoc Singapore VL - 111 UR - https://doi.org/10.1016/j.jfma.2012.01.003 DO - 10.1016/j.jfma.2012.01.003 ID - Ho2012 ER - TY - JOUR AU - Schnittger, S. AU - Bacher, U. AU - Eder, C. AU - Dicker, F. AU - Alpermann, T. AU - Grossmann, V. PY - 2012 DA - 2012// TI - Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow JO - Haematologica. VL - 97 UR - https://doi.org/10.3324/haematol.2012.064683 DO - 10.3324/haematol.2012.064683 ID - Schnittger2012 ER - TY - JOUR AU - Pagliarini-e-Silva, S. AU - Santos, B. C. AU - Pereira, E. M. AU - Ferreira, M. E. AU - Baraldi, E. C. AU - Sell, A. M. PY - 2013 DA - 2013// TI - Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population JO - Clinics (Sao Paulo). Brazil VL - 68 UR - https://doi.org/10.6061/clinics/2013(01)OA02 DO - 10.6061/clinics/2013(01)OA02 ID - Pagliarini-e-Silva2013 ER - TY - JOUR AU - Patriarca, A. AU - Colaizzo, D. AU - Tiscia, G. AU - Spadano, R. AU - Zacomo, S. AU - Spadano, A. PY - 2013 DA - 2013// TI - TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings JO - Biomed Res Int. United States VL - 2013 ID - Patriarca2013 ER - TY - JOUR AU - Kim, H. -. R. AU - Choi, H. -. J. AU - Kim, Y. -. K. AU - Kim, H. -. J. AU - Shin, J. -. H. AU - Suh, S. -. P. PY - 2013 DA - 2013// TI - Allelic expression imbalance of JAK2 V617F mutation in BCR-ABL negative myeloproliferative neoplasms JO - PLoS One United States VL - 8 UR - https://doi.org/10.1371/journal.pone.0052518 DO - 10.1371/journal.pone.0052518 ID - Kim2013 ER - TY - JOUR AU - Wu, Z. AU - Zhang, X. AU - Xu, X. AU - Chen, Y. AU - Hu, T. AU - Kang, Z. PY - 2014 DA - 2014// TI - The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms JO - J Hematol Oncol. England VL - 7 UR - https://doi.org/10.1186/s13045-014-0048-6 DO - 10.1186/s13045-014-0048-6 ID - Wu2014 ER - TY - JOUR AU - Payzin, K. B. AU - Savasoglu, K. AU - Alacacioglu, I. AU - Ozdemirkiran, F. AU - Mutlu, B. B. AU - Bener, S. PY - 2014 DA - 2014// TI - JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms JO - Clin Lymphoma Myeloma Leuk. United States VL - 14 UR - https://doi.org/10.1016/j.clml.2014.02.013 DO - 10.1016/j.clml.2014.02.013 ID - Payzin2014 ER - TY - JOUR AU - Macedo, L. C. AU - Santos, B. C. AU - Pagliarini-e-Silva, S. AU - Pagnano, K. B. B. AU - Rodrigues, C. AU - Quintero, F. C. PY - 2015 DA - 2015// TI - JAK2 46/1 haplotype is associated with JAK2 V617F--positive myeloproliferative neoplasms in Brazilian patients JO - Int J Lab Hematol England VL - 37 UR - https://doi.org/10.1111/ijlh.12380 DO - 10.1111/ijlh.12380 ID - Macedo2015 ER - TY - JOUR AU - Ouyang, Y. AU - Qiao, C. AU - Wang, J. AU - Xiao, L. AU - Zhang, S. PY - 2015 DA - 2015// TI - Analysis of CALR, JAK2 and MPL gene mutations in BCR-ABL negative myeloproliferative neoplasms JO - Zhonghua Yi Xue Za Zhi. China VL - 95 ID - Ouyang2015 ER - TY - JOUR AU - Mahjoub, S. AU - Baccouche, H. AU - Sahnoun, M. AU - Kaabi, H. AU - Manai, Z. AU - Slama, H. PY - 2015 DA - 2015// TI - The JAK2 mutation in myeloproliferative disorders: a predictive factor of thrombosis JO - Tunis med. Tunisia VL - 93 ID - Mahjoub2015 ER - TY - JOUR AU - Jaradat, S. A. AU - Khasawneh, R. AU - Kamal, N. AU - Matalka, I. AU - Al-Bishtawi, M. AU - Al-Sweedan, S. PY - 2015 DA - 2015// TI - Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms JO - Hematol Oncol Stem Cell Ther. England VL - 8 UR - https://doi.org/10.1016/j.hemonc.2015.07.004 DO - 10.1016/j.hemonc.2015.07.004 ID - Jaradat2015 ER - TY - JOUR AU - Labastida-Mercado, N. AU - Galindo-Becerra, S. AU - Garces-Eisele, J. AU - Colunga-Pedraza, P. AU - Guzman-Olvera, V. AU - Reyes-Nunez, V. PY - 2015 DA - 2015// TI - The mutation profile of JAK2, MPL and CALR in Mexican patients with Philadelphia chromosome-negative myeloproliferative neoplasms JO - Hematol Oncol Stem Cell Ther England VL - 8 UR - https://doi.org/10.1016/j.hemonc.2014.12.002 DO - 10.1016/j.hemonc.2014.12.002 ID - Labastida-Mercado2015 ER - TY - JOUR AU - Duangnapasatit, B. AU - Rattarittamrong, E. AU - Rattanathammethee, T. AU - Hantrakool, S. AU - Chai-Adisaksopha, C. AU - Tantiworawit, A. PY - 2015 DA - 2015// TI - Clinical manifestations and risk factors for complications of Philadelphia chromosome-negative myeloproliferative neoplasms JO - Asian Pac J Cancer Prev Thailand VL - 16 UR - https://doi.org/10.7314/APJCP.2015.16.12.5013 DO - 10.7314/APJCP.2015.16.12.5013 ID - Duangnapasatit2015 ER - TY - JOUR AU - Geduk, A. AU - Atesoglu, E. B. AU - Tarkun, P. AU - Mehtap, O. AU - Hacihanefioglu, A. AU - Demirsoy, E. T. PY - 2015 DA - 2015// TI - The role of beta-catenin in Bcr/Abl negative myeloproliferative neoplasms: An Immunohistochemical study JO - Clin Lymphoma Myeloma Leuk. United States VL - 15 UR - https://doi.org/10.1016/j.clml.2015.08.084 DO - 10.1016/j.clml.2015.08.084 ID - Geduk2015 ER - TY - JOUR AU - Lin, Y. AU - Liu, E. AU - Sun, Q. AU - Ma, J. AU - Li, Q. AU - Cao, Z. PY - 2015 DA - 2015// TI - The prevalence of JAK2, MPL, and CALR mutations in Chinese patients with BCR-ABL1-negative myeloproliferative neoplasms JO - Am J Clin Pathol VL - 144 UR - https://doi.org/10.1309/AJCPALP51XDIXDDV DO - 10.1309/AJCPALP51XDIXDDV ID - Lin2015 ER - TY - JOUR AU - Berzoti-Coelho, M. G. AU - Ferreira, A. F. AU - Souza, N. N. AU - Pinto, M. T. AU - Junior, M. C. R. AU - Simoes, B. P. PY - 2016 DA - 2016// TI - The expression of death inducer-obliterator (DIDO) variants in myeloproliferative neoplasms JO - Blood Cells Mol Dis. United States VL - 59 UR - https://doi.org/10.1016/j.bcmd.2016.03.008 DO - 10.1016/j.bcmd.2016.03.008 ID - Berzoti-Coelho2016 ER - TY - JOUR AU - Macedo, L. C. AU - Cesare, Q. F. AU - Pagliari-E-Silva, S. AU - Pagnano, K. B. B. AU - Rodrigues, C. AU - Alencar, J. B. PY - 2016 DA - 2016// TI - Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients JO - Blood Cells Mol Dis. United States VL - 57 UR - https://doi.org/10.1016/j.bcmd.2015.12.005 DO - 10.1016/j.bcmd.2015.12.005 ID - Macedo2016 ER - TY - JOUR AU - Didone, A. AU - Nardinelli, L. AU - Marchiani, M. AU - Ruiz, A. R. L. AU - Lima Costa, A. L. AU - Lima, I. S. PY - 2016 DA - 2016// TI - Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms JO - Pract Lab Med Netherlands VL - 4 UR - https://doi.org/10.1016/j.plabm.2015.12.004 DO - 10.1016/j.plabm.2015.12.004 ID - Didone2016 ER - TY - JOUR AU - Xu, J. AU - Xu, Z. AU - Wang, J. AU - Li, B. AU - Sun, X. AU - Qin, T. PY - 2016 DA - 2016// TI - The assessment of symptomatic burden among Ph/BCR- ABL negative myeloproliferative neoplasm patients JO - Zhonghua Xue ye Xue Za Zhi. China VL - 37 ID - Xu2016 ER - TY - JOUR AU - McFarland, D. C. AU - Polizzi, H. AU - Mascarenhas, J. AU - Kremyanskaya, M. AU - Holland, J. AU - Hoffman, R. PY - 2016 DA - 2016// TI - Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative Neoplasms JO - J Natl Compr Canc Netw. United States VL - 14 UR - https://doi.org/10.6004/jnccn.2016.0168 DO - 10.6004/jnccn.2016.0168 ID - McFarland2016 ER - TY - JOUR AU - Wang, J. C. AU - Kundra, A. AU - Andrei, M. AU - Baptiste, S. AU - Chen, C. AU - Wong, C. PY - 2016 DA - 2016// TI - Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm JO - Leuk Res. England VL - 43 UR - https://doi.org/10.1016/j.leukres.2016.02.004 DO - 10.1016/j.leukres.2016.02.004 ID - Wang2016 ER - TY - JOUR AU - Gardner, J. -. A. AU - Peterson, J. D. AU - Turner, S. A. AU - Soares, B. L. AU - Lancor, C. R. AU - Santos, L. L. PY - 2016 DA - 2016// TI - Detection of CALR mutation in clonal and nonclonal hematologic diseases using fragment analysis and next-generation sequencing JO - Am J Clin Pathol England VL - 146 UR - https://doi.org/10.1093/ajcp/aqw129 DO - 10.1093/ajcp/aqw129 ID - Gardner2016 ER - TY - JOUR AU - Delic, S. AU - Rose, D. AU - Kern, W. AU - Nadarajah, N. AU - Haferlach, C. AU - Haferlach, T. PY - 2016 DA - 2016// TI - Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera JO - Br J Haematol VL - 175 UR - https://doi.org/10.1111/bjh.14269 DO - 10.1111/bjh.14269 ID - Delic2016 ER - TY - JOUR AU - Orvain, C. AU - Luque Paz, D. AU - Dobo, I. AU - Cottin, L. AU - Calvez, G. AU - Chauveau, A. PY - 2016 DA - 2016// TI - Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study JO - Ann Hematol VL - 95 UR - https://doi.org/10.1007/s00277-016-2784-x DO - 10.1007/s00277-016-2784-x ID - Orvain2016 ER - TY - JOUR AU - Goel, S. AU - Paoli, C. AU - Iurlo, A. AU - Pereira, A. AU - Efficace, F. AU - Barbui, T. PY - 2017 DA - 2017// TI - Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms JO - Eur J Haematol. England VL - 99 UR - https://doi.org/10.1111/ejh.12887 DO - 10.1111/ejh.12887 ID - Goel2017 ER - TY - JOUR AU - Smaili, W. AU - Doubaj, Y. AU - Laarabi, F. Z. AU - Lyahyai, J. AU - Kerbout, M. AU - Mikdame, M. PY - 2017 DA - 2017// TI - CALR gene mutational profile in myeloproliferative neoplasms with non-mutated JAK2 in Moroccan patients: a case series and germline in-frame deletion JO - Curr Res Transl Med France VL - 65 UR - https://doi.org/10.1016/j.retram.2016.08.002 DO - 10.1016/j.retram.2016.08.002 ID - Smaili2017 ER - TY - JOUR AU - Gadomska, G. AU - Stankowska, K. AU - Boinska, J. AU - Slusarz, R. AU - Tylicka, M. AU - Michalska, M. PY - 2017 DA - 2017// TI - VEGF-A, sVEGFR-1, and sVEGFR-2 in BCR-ABL negative myeloproliferative neoplasms. Medicina (Kaunas) JO - Netherlands VL - 53 ID - Gadomska2017 ER - TY - JOUR AU - Yildiz, I. AU - Yokus, O. AU - Gedik, H. PY - 2017 DA - 2017// TI - Janus kinase 2 mutations in cases with BCR-ABL-negative chronic myeloproliferative disorders from Turkey JO - Avicenna J Med India VL - 7 UR - https://doi.org/10.4103/2231-0770.197511 DO - 10.4103/2231-0770.197511 ID - Yildiz2017 ER - TY - JOUR AU - Li, M. Y. AU - Chao, H. Y. AU - Sun, A. N. AU - Qiu, H. Y. AU - Jin, Z. M. AU - Tang, X. W. PY - 2017 DA - 2017// TI - Clinical significance of JAK2CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center JO - Zhonghua Xue Ye Xue Za Zhi VL - 38 ID - Li2017 ER - TY - JOUR AU - Misawa, K. AU - Yasuda, H. AU - Araki, M. AU - Ochiai, T. AU - Morishita, S. AU - Shirane, S. PY - 2018 DA - 2018// TI - Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms JO - Int J Hematol VL - 107 UR - https://doi.org/10.1007/s12185-018-2421-7 DO - 10.1007/s12185-018-2421-7 ID - Misawa2018 ER - TY - JOUR AU - Gango, A. AU - Mozes, R. AU - Boha, Z. AU - Kajtar, B. AU - Timar, B. AU - Kiraly, P. A. PY - 2018 DA - 2018// TI - Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms JO - Leuk Res VL - 65 UR - https://doi.org/10.1016/j.leukres.2017.12.005 DO - 10.1016/j.leukres.2017.12.005 ID - Gango2018 ER - TY - JOUR AU - Lim, Y. AU - Lee, J. O. AU - Bang, S. M. PY - 2016 DA - 2016// TI - Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea JO - J Korean Med Sci. Korea (South) VL - 31 UR - https://doi.org/10.3346/jkms.2016.31.10.1579 DO - 10.3346/jkms.2016.31.10.1579 ID - Lim2016 ER - TY - JOUR AU - Roaldsnes, C. AU - Holst, R. AU - Frederiksen, H. AU - Ghanima, W. PY - 2017 DA - 2017// TI - Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway JO - Eur J Haematol England VL - 98 UR - https://doi.org/10.1111/ejh.12788 DO - 10.1111/ejh.12788 ID - Roaldsnes2017 ER - TY - JOUR AU - Mughal, T. I. AU - Gotlib, J. AU - Mesa, R. AU - Koschmieder, S. AU - Khoury, H. J. AU - Cortes, J. E. PY - 2018 DA - 2018// TI - Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms JO - Leuk Res England VL - 67 UR - https://doi.org/10.1016/j.leukres.2018.02.008 DO - 10.1016/j.leukres.2018.02.008 ID - Mughal2018 ER - TY - STD TI - Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. Italy. 2010;102:83–7. ID - ref79 ER - TY - JOUR AU - Griesshammer, M. AU - Sadjadian, P. PY - 2017 DA - 2017// TI - The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium JO - Expert Opin Pharmacother England VL - 18 UR - https://doi.org/10.1080/14656566.2017.1404574 DO - 10.1080/14656566.2017.1404574 ID - Griesshammer2017 ER - TY - JOUR AU - Lundberg, P. AU - Karow, A. AU - Nienhold, R. AU - Looser, R. AU - Hao-Shen, H. AU - Nissen, I. AU - Girsberger, S. AU - Lehmann, T. AU - Passweg, J. AU - Stern, M. AU - Beisel, C. AU - Kralovics, R. AU - Skoda, R. C. PY - 2014 DA - 2014// TI - Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-11-537167 DO - 10.1182/blood-2013-11-537167 ID - Lundberg2014 ER - TY - JOUR AU - Bench, A. J. AU - White, H. E. AU - Foroni, L. AU - Godfrey, A. L. AU - Gerrard, G. AU - Akiki, S. PY - 2013 DA - 2013// TI - Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations JO - Br J Haematol VL - 160 UR - https://doi.org/10.1111/bjh.12075 DO - 10.1111/bjh.12075 ID - Bench2013 ER - TY - JOUR AU - Lavi, N. o. a. PY - 2014 DA - 2014// TI - Calreticulin Mutations in Myeloproliferative Neoplasms JO - Rambam Maimonides Medical Journal VL - 5 UR - https://doi.org/10.5041/RMMJ.10169 DO - 10.5041/RMMJ.10169 ID - Lavi2014 ER - TY - JOUR AU - Kralovics, R. AU - Passamonti, F. AU - Buser, A. S. AU - Teo, S. -. S. AU - Tiedt, R. AU - Passweg, J. R. PY - 2005 DA - 2005// TI - A gain-of-function mutation of JAK2 in myeloproliferative disorders JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa051113 DO - 10.1056/NEJMoa051113 ID - Kralovics2005 ER - TY - JOUR AU - Levine, R. L. AU - Wadleigh, M. AU - Cools, J. AU - Ebert, B. L. AU - Wernig, G. AU - Huntly, B. J. P. PY - 2005 DA - 2005// TI - Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis JO - Cancer Cell VL - 7 UR - https://doi.org/10.1016/j.ccr.2005.03.023 DO - 10.1016/j.ccr.2005.03.023 ID - Levine2005 ER - TY - JOUR AU - Saeidi, K. PY - 2016 DA - 2016// TI - Critical reviews in oncology / hematology myeloproliferative neoplasms: current molecular biology and genetics. Crit rev Oncol / Hematol JO - Elsevier Ireland Ltd VL - 98 ID - Saeidi2016 ER - TY - JOUR AU - Vannucchi, A. M. AU - Antonioli, E. AU - Guglielmelli, P. AU - Pancrazzi, A. AU - Guerini, V. AU - Barosi, G. PY - 2008 DA - 2008// TI - Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia JO - Blood. VL - 112 UR - https://doi.org/10.1182/blood-2008-01-135897 DO - 10.1182/blood-2008-01-135897 ID - Vannucchi2008 ER - TY - JOUR AU - Beer, P. A. AU - Campbell, P. J. AU - Scott, L. M. AU - Bench, A. J. AU - Erber, W. N. AU - Bareford, D. PY - 2008 DA - 2008// TI - MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort JO - Blood. VL - 112 UR - https://doi.org/10.1182/blood-2008-01-131664 DO - 10.1182/blood-2008-01-131664 ID - Beer2008 ER - TY - JOUR AU - Haider, M. AU - Elala, Y. C. AU - Gangat, N. AU - Hanson, C. A. AU - Tefferi, A. PY - 2016 DA - 2016// TI - MPL mutations and palpable splenomegaly are independent risk factors for fibrotic progression in essential thrombocythemia JO - Blood Cancer Journal VL - 6 UR - https://doi.org/10.1038/bcj.2016.98 DO - 10.1038/bcj.2016.98 ID - Haider2016 ER - TY - STD TI - Szuber N, Hanson CA, Lasho TL, Finke C, Ketterling RP, Pardanani A, et al. MPL-mutated essential thrombocythemia: a morphologic reappraisal. Blood cancer journal. United States. 2018;8:121. ID - ref90 ER -